PLAT and coronary artery disorder: We observed that patients who were older, received lower dose of tPA, had lower GCS and higher NIHSS score at baseline, co-morbid with diabetes mellitus (DM) and ischemic heart disease, and higher fasting glucose level, were more likely to die within the first 3 months after tPA therapy.